0001819790-24-000008.txt : 20240130 0001819790-24-000008.hdr.sgml : 20240130 20240130163148 ACCESSION NUMBER: 0001819790-24-000008 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240125 FILED AS OF DATE: 20240130 DATE AS OF CHANGE: 20240130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lin Elizabeth Yeu CENTRAL INDEX KEY: 0001842190 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39614 FILM NUMBER: 24578622 MAIL ADDRESS: STREET 1: 25651 ATLANTIC OCEAN DRIVE CITY: LAKE FOREST STATE: CA ZIP: 92630 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tarsus Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001819790 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 814717861 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 15440 LAGUNA CANYON ROAD CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: (949) 409-9820 MAIL ADDRESS: STREET 1: 15440 LAGUNA CANYON ROAD CITY: IRVINE STATE: CA ZIP: 92618 4 1 wk-form4_1706650295.xml FORM 4 X0508 4 2024-01-25 0 0001819790 Tarsus Pharmaceuticals, Inc. TARS 0001842190 Lin Elizabeth Yeu C/O TARSUS PHARMACEUTICALS, INC. 15440 LAGUNA CANYON ROAD, SUITE 160 IRVINE CA 92618 1 0 0 0 0 Stock Option (right to buy) 26.25 2024-01-25 4 A 0 10000 0 A 2034-01-24 Common Stock 10000 10000 D Option granted in connection with certain consulting services being provided by the Reporting Person. The option will vest in full on January 30, 2025, subject to the Reporting Person's continuous service through such date. /s/ Jeffrey Farrow, Attorney-in-Fact 2024-01-30